MarketInOut Stock Screener Log In | Sign Up
 

Nutriband Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Nutriband Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization70.14 mln
Float5.25 mln
Earnings Date12/11/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-5.85
Highly reliable

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-430%
Severely loss-making

ROE

-102
Deeply negative

Business Description

Nutriband Inc. is a Florida-based company focused on developing skin patch medications designed to reduce the risk of drug misuse and abuse. Its main product, AVERSA fentanyl, is a patch that delivers pain relief steadily over time while making it harder to misuse, targeting patients who need continuous opioid treatment for chronic pain. The company is also working on similar patch-based versions of buprenorphine and methylphenidate, and partners with Kindeva Drug Delivery to support its development and supply needs.

Key Fundamentals

EPS-0.53
ROE-102
RPS0.13
ROIC-254
ROA-88.52
Interest Cover-339
EBITDA, mln-6.80
EV / EBITDA-12.91
EV / EBIT-12.64
Revenue, mln1.62
EV / Revenue54.22

Quote Details

Last 5.76
Change -0.05 (-0.86%)
Open 5.94
Volume 6,646
Turnover 38,281
Average Volume 77,809

Financial Ratios

Pre-Tax Profit Margin-430
Leverage Ratio1.18
Current Ratio4.21
Price / Book17.00
Price / Tangible Book26.71
Debt / Equity0.04
Price / Sales55.80

Financial Strength

Altman Z-Score48.7
Piotroski F-Score 3 / 9
Beneish M-Score-5.85
Short Ratio1.10
Short % of Float2.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.4% 23 / 100   
1 Month -35.93% 7 / 100   
2 Months 87.01% 97 / 100   
6 Months 44% 91 / 100   
1 Year -18.18% 36 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog